A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma
about
Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-AnalysisA novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth.Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast CancerMDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinomaNuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistanceBasic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patientsObesity and Cancer: An Angiogenic and Inflammatory Link.The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody.Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells
P2860
Q26772984-6EC95102-EE4A-49C5-8CFF-3F60AC152460Q33877489-80FC63ED-B616-47AB-B31C-0425C2634E54Q34080323-8AB89AF3-646F-49F4-BF74-364F18FA2080Q34781101-24042A4A-E1B0-4909-9569-1169E0097661Q35816889-D45BAEC2-B026-4C00-88D8-14E7BECA57A3Q35879398-E0C0D99E-E94B-4817-B544-3DC89D016016Q36759129-590376EC-675B-4F1C-8924-CC02EE34ADF3Q38203467-067F0B31-A811-4322-8272-68BF5F057268Q39062384-8B8B6C82-4C5B-42B7-9321-280B4D032083Q40978947-AC104D4D-19EE-4060-9BAB-F216DC1FE36AQ47119535-71536CB4-A8E6-4F21-B199-6A687DFE95B5Q52655425-8F956140-D7B7-4320-8353-344BCF2A0D79Q55096590-B969A343-7B16-45D7-A767-0FA9C4B3C288Q58777990-76DB04C8-AD8E-4F98-B33C-1E3E6A644BF7
P2860
A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A proangiogenic signature is r ...... d neck squamous cell carcinoma
@en
A proangiogenic signature is r ...... neck squamous cell carcinoma.
@nl
type
label
A proangiogenic signature is r ...... d neck squamous cell carcinoma
@en
A proangiogenic signature is r ...... neck squamous cell carcinoma.
@nl
prefLabel
A proangiogenic signature is r ...... d neck squamous cell carcinoma
@en
A proangiogenic signature is r ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P1476
A proangiogenic signature is r ...... d neck squamous cell carcinoma
@en
P2093
Jeffrey N Myers
Marcus V Ortega Alves
Rekha Gyanchandani
Seungwon Kim
P2860
P304
P356
10.1158/1541-7786.MCR-13-0358
P577
2013-10-03T00:00:00Z